全文获取类型
收费全文 | 942篇 |
免费 | 18篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 34篇 |
妇产科学 | 75篇 |
基础医学 | 46篇 |
口腔科学 | 17篇 |
临床医学 | 29篇 |
内科学 | 88篇 |
皮肤病学 | 9篇 |
神经病学 | 28篇 |
特种医学 | 13篇 |
外科学 | 562篇 |
综合类 | 1篇 |
预防医学 | 11篇 |
眼科学 | 8篇 |
药学 | 10篇 |
肿瘤学 | 14篇 |
出版年
2023年 | 7篇 |
2022年 | 6篇 |
2021年 | 17篇 |
2020年 | 12篇 |
2019年 | 15篇 |
2018年 | 14篇 |
2017年 | 15篇 |
2016年 | 12篇 |
2015年 | 13篇 |
2014年 | 23篇 |
2013年 | 21篇 |
2012年 | 33篇 |
2011年 | 45篇 |
2010年 | 18篇 |
2009年 | 36篇 |
2008年 | 67篇 |
2007年 | 91篇 |
2006年 | 106篇 |
2005年 | 84篇 |
2004年 | 72篇 |
2003年 | 56篇 |
2002年 | 42篇 |
2001年 | 33篇 |
2000年 | 20篇 |
1999年 | 41篇 |
1998年 | 4篇 |
1997年 | 5篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1993年 | 1篇 |
1992年 | 19篇 |
1991年 | 10篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1978年 | 2篇 |
1975年 | 1篇 |
排序方式: 共有961条查询结果,搜索用时 0 毫秒
1.
Feza Karakayali Nihan Haberal Hale Tufan Nesrin Hasirci Ozgur Basaran Sinasi Sevmis Aydin Akdur Aysel Kiziltay Mehmet Haberal 《Journal of investigative surgery》2007,20(3):167-173
Tranilast is an antiallergic drug that interferes with proliferation and migration of vascular smooth muscle cell induced by platelet-derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1). We investigated the local effect of tranilast on neointimal hyperplasia using tranilast-coated prosthetic grafts. The inner sides of the thin-walled polytetrafluoroethylene (PTFE) grafts were coated with chitosan and tranilast containing chitosan solution. Wistar albino rats (32) were used in the study. Patches (1 x 2 mm) for vascular grafts were prepared. Three groups were tested: group 1 (n = 12; tranilast coated), group 2 (n = 10; adhesive-only film-layer-coated), and group 3 (n = 10; normal ePTFE patch grafts sutured to the carotid arteries of the rats). Recipient sites of the carotid arteries were excised 4 weeks after surgery. All sections were examined histologically for graft patency, thrombus formation, and neointimal thickness. Expression of PDGF, fibroblast growth factor, and TGF-beta1 on cross-sections of the neointima were evaluated by immunohistochemistry. No significant differences were found regarding mean neointimal thicknesses. PDGF and TGF-beta-1 expressions were significantly lower in group 1. Although a decrease in local effect of tranilast was observed for growth factor expressions at a drug concentration of 0.05 mg/cm(2), a significant reduction in neointimal hyperplasia was not achieved. The coating concentration of 0.05 mg/cm(2) may have been too low to produce an antiproliferative effect. Given our promising results, further studies are recommended and planned using different drug concentrations and time intervals. 相似文献
2.
Kaan Kirali Nihan Kayalar Tuncer Ko?ak Cevat Yakut 《European journal of cardio-thoracic surgery》2005,27(5):923-924
Many approaches for minimally invasive coronary bypass surgery are available and to further decrease the invasiveness, coronary artery bypass grafting has been performed under high thoracic epidural anesthesia without endotracheal intubation in the last years. Less invasive approach to coronary artery bypass graft operations is possible through combination of the high thoracic epidural anesthesia and a reversed-J sternotomy, and coronary revascularization can be accomplished without any additional technical difficulties and with a good exposure of both the left anterior descending artery and the left internal thoracic artery. This technique is less traumatic for patients and provides practical better oxygenation and shorter hospital stay. 相似文献
3.
Ozgur O; Boyacioglu S; Ozdogan M; Gur G; Telatar H; Haberal M 《Nephrology, dialysis, transplantation》1997,12(2):289-291
Background. It is known that Helicobacter
pylori (Hp) plays an important role in gastritis and peptic
ulcer disease in the general population. Although dyspeptic complaints are
frequent in haemodialysis (HD) patients and renal transplant recipients,
there are few reports regarding the prevalence of Hp and its possible
effects on this group of patients. This study was performed to examine the
prevalence of Hp infection in patients on regular HD treatment and to
detect its role in the pathogenesis of dyspepsia in this group of patients.
Methods. Two hundred and one patients with dyspeptic
complaints were included in the study. The groups consisted of 47 HD, 54
renal transplant recipients, and 100 non-renal disease patients. Upper
gastrointestinal endoscopies were performed and gastric antral biopsies
were obtained for urease test in all patients.
Results. Twenty-eight (60%) of the 47 HD and 28 (70%)
of the 54 RTR were positive for Hp. Sixty-four (64%) of the 100 patients
with various gastrointestinal complaints and known to have no renal
dysfunction were positive for Hp. The Hp prevalences among the three groups
were not significantly different (P <0.05). The prevalence of Hp
infection did not correlate with the haemodialysis duration nor the
post-transplantation duration (P <0.05). There was no correlation
between the prevalence of Hp infection and duration of haemodialysis
therapy or time post-transplantation. Conclusion.
These findings suggest that HD patients are not protected against Hp
infection as the Hp prevalences are as high as that for the non-renal
disease group. The increased dyspeptic complaints may be partly related to
Hp infection. 相似文献
4.
5.
6.
Recombinant {alpha}-interferon in renal allograft recipients with chronic hepatitis C 总被引:5,自引:0,他引:5
Ozgur O.; Boyacioglu S.; Telatar H.; Haberal M. 《Nephrology, dialysis, transplantation》1995,10(11):2104-2106
BACKGROUND.: Although chronic hepatitis C infection is one of the factorsthat can lead to morbidity and mortality in renal allograftrecipients, treatment procedures have not been well documented.Interferon treatment has been shown to be effective in the normalizationof biochemical hepatitis C and in the clearing of hepatitisC virus RNA. However, little is known concerning the efficacyand safety of interferon treatment in renal allograft recipientswith chronic hepatitis C. Interferon has also been accused ofincreasing renal allograft rejection. METHODS.: Recombinant -interferon in a dose of 4.5 million units threetimes per week was given to five renal-allograft recipientswith chronic hepatitis C for 6 months. Besides biochemical investigations,liver histopathologies before and after the treatment coursewere also studied. RESULTS.: Interferon treatment was effective in two of the patients, inanother two cases renal function deteriorated during the treatment.In the last case ALT increased again after cessation of interferontherapy. CONCLUSION.: We conclude that interferon seems to be moderately effectivein treating chronic hepatitis C in renal allograft recipients,but a risk of renal functional deterioration and rejection remains. 相似文献
7.
Whether a flap can be raised successfully in a body region that has been subjected to burn injury remains an issue. The aim of this study was to investigate the survival of skin flaps that were elevated after superficial and deep partial-thickness burn injury in a rat model. Sixty-five rats were divided into five groups: Group 1 (N = 15) was the control group, group 2 (N = 10) included rats with superficial partial-thickness burns that had flaps elevated on day 0, group 3 (N = 15) was comprised up of rats with superficial partial-thickness burns that had flaps elevated on day 4, group 4 (N = 10) included rats with deep partial-thickness burns that had flaps elevated on day 0, and group 5 (N = 15) was comprised of rats with deep partial-thickness burns that had flaps elevated on day 4. Caudally based dorsal flaps consisting of skin and panniculus carnosus were elevated in all groups, and the amount of surviving tissue on each flap was quantified. The surviving areas of flaps elevated on postburn days 0 and 4 in superficial partial-thickness burn zones (groups 2 and 3) were larger than those of flaps that were elevated on postburn days 0 and 4 in deep partial-thickness burn zones (groups 4 and 5). The surviving portions of flaps that were elevated on day 4 in superficial partial-thickness burn zones (group 3) were similar to the surviving areas of flaps in the control group (group 1), and were larger than those of all other groups (groups 2, 4, and 5). In this rat model, flaps were elevated in superficial dermal burn zones with successful outcomes. However, raising flaps in deep dermal burn zones was not a reliable method. 相似文献
8.
9.
10.